DEL‐1 Protects the Myocardium From Ischemia/Hypoxia Injury Through Regulating the Sirt1/NF‐κB Signaling Pathway
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Bin Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Sirtuin 1, NF-kappa B, Myocardial Infarction, Myocardium. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Natural Science Foundation of Shandong Province of China (ZR2020QH025)..
Abstract (Originalsprache)
Purpose
Our study intended to explore the function and the potential mechanisms of developmental endothelial locus‐1 (DEL‐1) to alleviate myocardial infarction (MI).
Methods
First, adeno‐associated viral containing DEL‐1 cDNA was injected into the myocardium of SD rats, and pcDNA‐DEL‐1 or Sirt1 siRNA was transfected into cardiomyocytes. Next, an MI model in vivo and a hypoxia model in vitro were established. The expression of DEL‐1 in MI rats and hypoxia‐induced cardiomyocytes was detected by qRT‐PCR, Western blot analysis, and immunofluorescence staining. The functions of DEL‐1 in vivo were investigated utilizing qRT‐PCR, echocardiography, hematoxylin and eosin staining, Masson's trichrome staining, Western blot analysis, TUNEL staining, and detection of hemodynamics, lactate dehydrogenase, and creatine kinase‐MB. The functions of DEL‐1 in vitro were investigated utilizing qRT‐PCR, Western blot analysis, ELISA, flow cytometry, co‐culture of cardiac cardiomyocytes and fibroblasts, transwell assay, and immunofluorescence staining.
Results
DEL‐1 expression was downregulated in MI rats and hypoxia‐induced cardiomyocytes. DEL‐1 overexpression alleviated cardiac dysfunction, myocardial fibrosis, inflammation, and cardiomyocyte apoptosis in MI rats. In vitro, DEL‐1 overexpression alleviated cardiomyocyte apoptosis and inflammation. Moreover, we also confirmed that DEL‐1 secreted by cardiomyocytes activated cardiac fibroblasts through paracrine signaling. Besides, DEL‐1 regulated the Sirt1/NF‐κB pathway in vitro and in vivo. However, the downregulation of Sirt1 reversed the effect of DEL‐1 on cardiomyocyte apoptosis and inflammation.
Conclusion
DEL‐1 could alleviate myocardial damage induced by MI via regulating the Sirt1/NF‐κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
ORCID-Profile: Hao Lin
Förderung
- This study was funded by the Natural Science Foundation of Shandong Province of China (ZR2020QH025).
Zitieren
APA
Hu, B., Zhang, W., Yu, W. C., & Lin, H. (2025). DEL‐1 Protects the Myocardium From Ischemia/Hypoxia Injury Through Regulating the Sirt1/NF‐κB Signaling Pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70288
Vancouver
Hu B, Zhang W, Yu WC, Lin H. DEL‐1 Protects the Myocardium From Ischemia/Hypoxia Injury Through Regulating the Sirt1/NF‐κB Signaling Pathway. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70288
BibTeX
@article{Hu2025,
author = {Hu, Bin and Zhang, Wenlong and Yu, Wan-Cheng and Lin, Hao},
title = {DEL‐1 Protects the Myocardium From Ischemia/Hypoxia Injury Through Regulating the Sirt1/NF‐κB Signaling Pathway},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70288}
}
EUVIMED